Recently, XtalPi, a drug research and development company with computational innovation, announced that it has completed a $46 million (about 320 million yuan) B+ round of financing, led by China Life Health Fund, SIG (Haina Asia) ), Yayi Capital and investment. The financing will be used to accelerate the expansion of Jingtai Technology's business and the development of a smart drug research and development platform to help its technology achieve application in more drug research and development. Prior to this, Jingtai Technology has received Ten rounds of investment from Tencent, Zhenge Fund and Fengrui Capital, and approximately $15 million in Series B financing from Sequoia, Google and Tencent. The accumulated financing exceeded US$66 million. . Jingtai Technology was founded in 2014 on the MIT campus. Its core headquarters is located in Shenzhen and has branches in Beijing and Boston. Based on cutting-edge technologies such as computational physics, quantum chemistry, molecular dynamics, artificial intelligence and cloud computing, Jingtai Technology provides fast and accurate intelligent drug development technology for innovative pharmaceutical companies around the world, thereby significantly improving the key to drug discovery and development. The efficiency and success rate of the link, reduce the cost of research and development, and ultimately bring more high-quality and effective drugs to patients. Jingtai Technology has established in-depth cooperation with many of the world's top pharmaceutical companies and scientific research institutions. In May this year, Jingtai Technology announced a strategic R&D cooperation with Pfizer's US R&D Center, combining artificial intelligence and quantum physics to develop drug molecules for Pfizer. Simulate the platform to improve its drug design capabilities and efficiency. After a new round of financing, Jingtai Technology will focus on deploying artificial intelligence algorithms in key areas of drug development, providing new drug discovery, predicting the key properties of drugs, and optimizing the process of drug development in a broader chemical space. New artificial intelligence algorithm application. Jingtai Technology will also upgrade its existing million-core cloud resource scheduling platform to create an industry-leading cloud R&D platform at the computing power and security level, providing highly customized solutions for pharmaceutical companies. Wen Jiehao, co-founder and chairman of Jingtai Technology, said: “Jingtai Technology has been highly recognized by customers in the pharmaceutical industry for innovative pharmaceutical companies. In the future, we also plan to open up the computing resource scheduling and security underlying platform to more worldwide. Drug development tool developers, connecting more AI drug development tools for the industry, empowering drug discovery organizations around the world to improve the efficiency of new drug discovery and drug product development." Wan Yiqing, president of China Life Insurance Fund, said, “The company’s core technical strength has always been an important criterion in the investment process of China Life Insurance Fund. Jingtai Technology is a leading company engaged in AI+ pharmaceutical research and development, its unique crystal form. Design and smart drug research and development technology has great potential for development, and I believe that the future will play a more important role in the field of pharmaceutical research and development." Liu Yi, a partner of Yayi Capital, said: “Jingtai Technology is the first company in the field of biotechnology to realize the application of quantum physics, artificial intelligence, and cloud computing in research and development. Its core technology has the opportunity to bring efficiency to the drug research and development industry. A revolutionary increase in success rate. We hope to support this forward-looking team to accelerate growth and enable the ID4 platform to contribute to more new drug development and benefit more patients." Frozen Pud Red Shrimp,Red Shrimp,Frozen Shrimp,Melantho Shrimp Zhoushan Haiwang Seafood Co., Ltd. , https://www.haiwangseafoods.com
AI-driven drug research and development, Jingtai Technology won $46 million B+ round investment